Cabinet clears KKR’s proposal to acquire stakes in two pharma companies
The two deals are estimated to be worth Rs 1,434 crores
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Novartis granted injunctions against four other generic makers over Galvus
Novartis filed an RTI with the DCGI seeking information regarding regulatory approvals issued for Vildagliptin
IDMA organises conference on ’Current Challenges & Opportunities in Pharma…
More than 50 participants from across the industry attended the day-long conference
3rd Global Pharma Regulatory Summit concludes in Mumbai
Experts from overseas and India discuss regulatory issues related to different pharma markets
7th International Conference of SAC-ACCP held in Mumbai
The theme for this year's conference was translational research
GAVI calls for renewed efforts by India’s new govt to bolster routine immunisation
This year India will continue the national roll-out of the 5-in-1 pentavalent vaccine
M&A activity focussed on portfolio transformation
Indian pharma sector witnessed one deal in April 2014, against the average of 0.8 deals over the previous six months
Re-skilling: An urgent need
There is an inadequate emphasis on re-skilling and re-training in the Indian pharmaceutical industry. However, when planned…
’I value exp erience over qualification’
Learning, of course, need to be a continuous process not only for better earning, but also for quality of life and healthy living.…